City of Hope Appoints Alan H. Bryce, M.D., as Chief Clinical Officer at City of Hope Cancer Center Phoenix and Professor of Molecular Medicine at TGen
City of Hope, one of the largest cancer research and treatment organizations in the United States, today announced the appointment of Alan H. Bryce , M.D., as the chief clinical officer at City of Hope Cancer Center Phoenix and professor of molecular medicine at Translational Genomics Research Institute (TGen), part of City of Hope.
- City of Hope, one of the largest cancer research and treatment organizations in the United States, today announced the appointment of Alan H. Bryce , M.D., as the chief clinical officer at City of Hope Cancer Center Phoenix and professor of molecular medicine at Translational Genomics Research Institute (TGen), part of City of Hope.
- View the full release here: https://www.businesswire.com/news/home/20231107722066/en/
City of Hope appoints Alan H. Bryce, M.D., as chief clinical officer at City of Hope Cancer Center Phoenix and professor of molecular medicine at TGen. - (Photo: City of Hope)
“We are excited to welcome Dr. Bryce to City of Hope Cancer Center Phoenix and look forward to his leadership in delivering advanced cancer care to Arizona patients,” said Kevin Tulipana, D.O., M.S., president of City of Hope Cancer Center Phoenix. - “I am delighted to welcome Dr. Bryce to City of Hope and TGen,” said Jeffrey M. Trent, Ph.D., TGen president and research director.